Spike Glycoprotein-Mediated Entry of SARS Coronaviruses

Severe acute respiratory syndrome coronavirus (SARS-CoV) and SARS-CoV-2 are enveloped, positive-sense, single-stranded RNA viruses and causes of epidemic diseases that have resulted in public health emergencies worldwide. Angiotensin-converting enzyme 2 (ACE2) is the receptor that allows the entry o...

Full description

Bibliographic Details
Main Authors: Lin Wang, Ye Xiang
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/12/11/1289
id doaj-f9da053271c346bfbe2e3ddcb274a613
record_format Article
spelling doaj-f9da053271c346bfbe2e3ddcb274a6132020-11-25T03:57:01ZengMDPI AGViruses1999-49152020-11-01121289128910.3390/v12111289Spike Glycoprotein-Mediated Entry of SARS CoronavirusesLin Wang0Ye Xiang1Center for Infectious Disease Research, Beijing Frontier Research Center for Biological Structure & Beijing Advanced Innovation Center for Structural Biology, Department of Basic Medical Sciences, School of Medicine, Tsinghua University, Beijing 100084, ChinaCenter for Infectious Disease Research, Beijing Frontier Research Center for Biological Structure & Beijing Advanced Innovation Center for Structural Biology, Department of Basic Medical Sciences, School of Medicine, Tsinghua University, Beijing 100084, ChinaSevere acute respiratory syndrome coronavirus (SARS-CoV) and SARS-CoV-2 are enveloped, positive-sense, single-stranded RNA viruses and causes of epidemic diseases that have resulted in public health emergencies worldwide. Angiotensin-converting enzyme 2 (ACE2) is the receptor that allows the entry of these two viruses into host cells, a key step in the life cycle of the pathogens. The characterization of the interactions of ACE2 with the viral spike glycoproteins and structural studies of the ACE2-binding-induced conformational changes in the viral spike glycoproteins have furthered our understanding of the entry processes of these two viruses, and these studies provide useful information that will facilitate the development of antiviral agents and vaccines to control the diseases.https://www.mdpi.com/1999-4915/12/11/1289SARS coronavirusesCOVID-19spike glycoproteinentryreceptor bindingconformational change
collection DOAJ
language English
format Article
sources DOAJ
author Lin Wang
Ye Xiang
spellingShingle Lin Wang
Ye Xiang
Spike Glycoprotein-Mediated Entry of SARS Coronaviruses
Viruses
SARS coronaviruses
COVID-19
spike glycoprotein
entry
receptor binding
conformational change
author_facet Lin Wang
Ye Xiang
author_sort Lin Wang
title Spike Glycoprotein-Mediated Entry of SARS Coronaviruses
title_short Spike Glycoprotein-Mediated Entry of SARS Coronaviruses
title_full Spike Glycoprotein-Mediated Entry of SARS Coronaviruses
title_fullStr Spike Glycoprotein-Mediated Entry of SARS Coronaviruses
title_full_unstemmed Spike Glycoprotein-Mediated Entry of SARS Coronaviruses
title_sort spike glycoprotein-mediated entry of sars coronaviruses
publisher MDPI AG
series Viruses
issn 1999-4915
publishDate 2020-11-01
description Severe acute respiratory syndrome coronavirus (SARS-CoV) and SARS-CoV-2 are enveloped, positive-sense, single-stranded RNA viruses and causes of epidemic diseases that have resulted in public health emergencies worldwide. Angiotensin-converting enzyme 2 (ACE2) is the receptor that allows the entry of these two viruses into host cells, a key step in the life cycle of the pathogens. The characterization of the interactions of ACE2 with the viral spike glycoproteins and structural studies of the ACE2-binding-induced conformational changes in the viral spike glycoproteins have furthered our understanding of the entry processes of these two viruses, and these studies provide useful information that will facilitate the development of antiviral agents and vaccines to control the diseases.
topic SARS coronaviruses
COVID-19
spike glycoprotein
entry
receptor binding
conformational change
url https://www.mdpi.com/1999-4915/12/11/1289
work_keys_str_mv AT linwang spikeglycoproteinmediatedentryofsarscoronaviruses
AT yexiang spikeglycoproteinmediatedentryofsarscoronaviruses
_version_ 1724462456575623168